Endpoints in Heart Failure Drug Development: History and Future

MLA

Mona, Fiuzat, et al. “Endpoints in Heart Failure Drug Development: History and Future.” JACC. Heart Failure, vol. 8, no. 6, Sept. 2019. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........9088dc50a9ad961e5165a0d7fdabeea8&authtype=sso&custid=ns315887.

APA

Mona, F., Naomi, L., Norman, S., Marco, S., Federica, L., JoAnn, L., Eldrin F, L., William T, A., John, T., Mary, W., Paul, H., Biykem, B., Randall C, S., Scott, S., G Michael, F., Javed, B., Clyde, Y., Lynne W, S., Christopher, O., … John, M. (2019). Endpoints in Heart Failure Drug Development: History and Future. JACC. Heart Failure, 8(6).

Chicago

Mona, Fiuzat, Lowy Naomi, Stockbridge Norman, Sbolli Marco, Latta Federica, Lindenfeld JoAnn, Lewis Eldrin F, et al. 2019. “Endpoints in Heart Failure Drug Development: History and Future.” JACC. Heart Failure 8 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........9088dc50a9ad961e5165a0d7fdabeea8&authtype=sso&custid=ns315887.